OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways

Author：            

Publisher： Spandidos Publications

E-ISSN： 1791-2423|47|5|1703-1710

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.47, Iss.5, 2015-01, pp. : 1703-1710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas

By Sierra A.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 1, 1999-03 ,pp. : 39-45

Springer Publishing Company

Access to resources Recommend Favorite

Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma

By                

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 778-784

Spandidos Publications

Access to resources Recommend Favorite

Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells

By          

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4508-4513

Spandidos Publications

Access to resources Recommend Favorite

Combination Antigene Therapy Targeting c-myc and c-erbB 2 in the Ovarian Cancer COC 1 Cell Line

By Fei R.   Shaoyang L.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 40-44

Elsevier

Access to resources Recommend Favorite

bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer

By Popescu R.A.   Lohri A.   de Kant E.   Thiede C.   Reuter J.   Herrmann R.   Rochlitz C.F.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1268-1273

Elsevier

Access to resources Recommend Favorite